PTEN RESEARCH FOUNDATION — grant history
Latest income
£716k
Grants listed (FY2025)
19
Listed grants total
£5.4m
Accounts grants total
£2.3m
listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts
Application guidance — from the funder’s own website
- Deadlines: • Project Proposal submission deadline: 25 November 2025 • Invitations to submit a Full Application: By end of January 2026 • Full Application submission deadline: 3 April 2026 • Applicants notified of outcome of application: by the end of October 2026
- What they don’t fund: Our position is that we only support direct costs that are all those eligible costs which can be attributed directly to an award grant. To this effect, we will not ordinarily fund “overheads” or “indirect costs”.
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| new | Boston Gene | — | £135k |
| new | University of Alabama | — | £55k |
| new | Ohio State University | — | £23k |
| new | Histologix | — | £14k |
| up | Geisel School of Medicine | £97k | £949k |
| up | Children’s Hospital of Philadelphia | £51k | £411k |
| up | The Cleveland Clinic | £30k | £110k |
| up | Institut Josep Carreras | £45k | £79k |
| up | Taconic Biosciences | £50k | £78k |
| down | University of British Columbia | £220k | £73k |
| down | Evotec International GmbH | £949k | £51k |
| up | John Carroll University | £8k | £40k |
| not listed | Radboud University Medical Centre | £38k | — |
| not listed | Developmental Synaptopathies Consortium | £0 | — |
| not listed | University of Melbourne | £0 | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University Hospital Southampton NHS Foundation | FY2025 | £2.2m | Research projects and clinical trials |
| Charles River Laboratories International Inc. | FY2025 | £1.1m | Research projects and clinical trials |
| Geisel School of Medicine | FY2025 | £949k | Research projects and clinical trials |
| Children’s Hospital of Philadelphia | FY2025 | £411k | Research projects and clinical trials |
| Boston Gene | FY2025 | £135k | Research projects and clinical trials |
| The Cleveland Clinic | FY2025 | £110k | Research projects and clinical trials |
| Institut Josep Carreras | FY2025 | £79k | Research projects and clinical trials |
| Taconic Biosciences | FY2025 | £78k | Research projects and clinical trials |
| University of British Columbia | FY2025 | £73k | Research projects and clinical trials |
| University of Alabama | FY2025 | £55k | Research projects and clinical trials |
| Evotec International GmbH | FY2025 | £51k | Research projects and clinical trials |
| John Carroll University | FY2025 | £40k | Research projects and clinical trials |
| Generon Ltd. | FY2025 | £29k | Research projects and clinical trials |
| Ohio State University | FY2025 | £23k | Research projects and clinical trials |
| Renown Health Foundation | FY2025 | £22k | Research projects and clinical trials |
| University College London | FY2025 | £19k | Research projects and clinical trials |
| Histologix | FY2025 | £14k | Research projects and clinical trials |
| Boston Children’s Hospital | FY2025 | £8k | Research projects and clinical trials |
| Cambridge University | FY2025 | £6k | Research projects and clinical trials |
| University Hospital Southampton NHS Foundation | FY2024 | £3.3m | |
| Charles River Laboratories International Inc. | FY2024 | £1.5m | |
| Evotec International GmbH | FY2024 | £949k | |
| University of British Columbia | FY2024 | £220k | |
| Boston Children’s Hospital | FY2024 | £187k | |
| Geisel School of Medicine | FY2024 | £97k | |
| Renown Health Foundation | FY2024 | £63k | |
| Children’s Hospital of Philadelphia | FY2024 | £51k | |
| Taconic Biosciences | FY2024 | £50k | |
| Institut Josep Carreras | FY2024 | £45k | |
| Radboud University Medical Centre | FY2024 | £38k | |
| The Cleveland Clinic | FY2024 | £30k | |
| University College London | FY2024 | £24k | |
| Generon Ltd. | FY2024 | £16k | |
| John Carroll University | FY2024 | £8k | |
| Cambridge University | FY2024 | £6k | |
| Developmental Synaptopathies Consortium | FY2024 | £0 | |
| University of Melbourne | FY2024 | £0 | |
| Charles River Laboratories | FY2022 | £382k | |
| University College London | FY2022 | £365k | |
| Bellvitge Biomedical Research Institute | FY2022 | £235k | |
| Radboud University Medical Center | FY2022 | £106k | |
| Renown Health Foundation | FY2022 | £82k | |
| Evotec International | FY2022 | £74k | |
| Boston Children's Hospital | FY2022 | £74k | |
| TC Istanbul Bilim University | FY2022 | £74k | |
| John Carroll University | FY2022 | £66k | |
| Beth Israel Deaconess Medical Centre | FY2022 | £51k | |
| IDIBELL | FY2022 | £44k | |
| Cambridge University | FY2022 | £38k | |
| Institut Josep Carreras | FY2022 | £34k | |
| AstraZeneca | FY2022 | £33k | |
| University of Melbourne | FY2022 | £29k | |
| Cleveland Clinic | FY2022 | £27k | |
| Imagen Therapeutics | FY2022 | £26k | |
| Children's Hospital of Philadelphia | FY2022 | £26k | |
| Developmental Synaptopathies Consortium | FY2022 | £25k | |
| Ohio State University | FY2022 | £16k | |
| Biocruces Bizkaia Health Research Institute | FY2022 | £-2k |